FAST1 Predicts Poor Survival of Renal Carcinoma and Promotes Its Progression Through the TGF-β/Smad Pathway

References

• Wang AB, Bao Y, Wu ZJ, et al. Long noncoding RNA EGFR-AS1 promotes cell growth and metastasis via affecting HuR mediated mRNA stability of EGFR in renal cancer. Cell Death Dis. 2019;10(3):154. doi:10.1038/s41419-019-1331-9
   PubMed Web of Science ®Google Scholar
• Liu XB, Hao YX, Yu W, et al. Long non-coding RNA emergence during renal cell carcinoma tumorigenesis. Cell Physiol Biochem. 2018;47(2):735–746. doi:10.1159/000490026
   PubMedGoogle Scholar
• Wang L, Su Y, Huang C, et al. FOXH1 is regulated by NANOG and LIN28 for early-stage reprogramming. Sci Rep. 2019;9(1):16443. doi:10.1038/s41598-019-52861-8
   PubMedGoogle Scholar
• Roessler E, Ouspenskaia MV, Karkera JD, et al. Reduced NODAL signaling strength via mutation of several pathway members, including FOXH1, is linked to human heart defects and holoprosencephaly. Am J Hum Genet. 2008;83(1):18–29. doi:10.1016/j.ajhg.2008.05.012
   PubMed Web of Science ®Google Scholar
• Cheng Q, Shi YJ, Li Z, Kang H, Xiang Z, Kong LF. FAST1 promotes the migration and invasion of colorectal cancer cells. Biochem Biophys Res Commun. 2019;509(2):407–413. doi:10.1016/j.bbrc.2018.12.122
   PubMed Web of Science ®Google Scholar
• Huang CX, Chen N, Wu XJ, et al. Zebrafish let-7b acts downstream of hypoxia-inducible factor-1α to assist in hypoxia-mediated cell proliferation and cell cycle regulation. Life Sci. 2017;171:21–29. doi:10.1016/j.lfs.2017.01.005
   PubMed Web of Science ®Google Scholar
• Connolly EC, Freimuth J, Akhurst RJ. Complexities of TGF-β targeted cancer therapy. Int J Biol Sci. 2012;8(7):964–978. doi:10.7150/ijbs.4564
   PubMed Web of Science ®Google Scholar
• Oshimori N, Oristian D, Fuchs E. TGF-β promotes heterogeneity and drug resistance in squamous cell carcinoma. Cell. 2015;160(5):963–976. doi:10.1016/j.cell.2015.01.043
   PubMed Web of Science ®Google Scholar
• Massagué J, Seoane J, Wotton D, et al. Smad transcription factors. Genes Dev. 2005;19(23):2783–2810. doi:10.1101/gad.1350705
   PubMed Web of Science ®Google Scholar
• Rouce RH, Shaim H, Sekine T, et al. The TGF-β/SMAD pathway is an important mechanism for NK cell immune evasion in childhood B-acute lymphoblastic leukemia. Leukemia. 2016;30(4):800–811. doi:10.1038/leu.2015.327
   PubMed Web of Science ®Google Scholar
• Liu LJ, Yu JJ, Xu XL. MicroRNA-93 inhibits apoptosis and promotes proliferation, invasion and migration of renal cell carcinoma ACHN cells via the TGF-β/Smad signaling pathway by targeting RUNX3. Am J Transl Res. 2017;9(7):3499–3513.
   PubMed Web of Science ®Google Scholar
• Weisberg E, Winnier GE, Chen X, Farnsworth CL, Hogan BL, Whitman M. A mouse homologue of FAST-1 transduces TGF beta superfamily signals and is expressed during early embryogenesis. Mech Dev. 1998;79(1–2):17–27. doi:10.1016/S0925-4773(98)00160-9
   PubMed Web of Science ®Google Scholar
• Franceschini A, Szklarczyk D, Frankild S, et al. STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 2013;41(Databaseissue):D808–D815. doi:10.1093/nar/gks1094
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30. doi:10.3322/caac.21332
   PubMed Web of Science ®Google Scholar
• Zhu H. Forkhead box transcription factors in embryonic heart development and congenital heart disease. Life Sci. 2016;144:194–201. doi:10.1016/j.lfs.2015.12.001
   PubMed Web of Science ®Google Scholar
• Wu Q, Zheng J, Dou C, Qi S. Forkhead box M1 promotes the growth and tube formation of human malignant meningioma cells via the aryl hydrocarbon receptor signaling pathway. Folia Neuropathol. 2020;58(3):223–236. doi:10.5114/fn.2020.100065
   PubMed Web of Science ®Google Scholar
• Liu F, Li N, Liu Y, Zhang J, Zhang J, Wang Z. Homeodomain interacting protein kinase-2 phosphorylates FOXM1 and promotes FOXM1-mediated tumor growth in renal cell carcinoma. J Cell Biochem. 2019;120(6):10391–10401. doi:10.1002/jcb.28323
   PubMed Web of Science ®Google Scholar
• Tong Z, Meng X, Wang J, Wang L. MicroRNA-212 inhibits the proliferation and invasion of human renal cell carcinoma by targeting FOXA1. Mol Med Rep. 2018;17(1):1361–1367. doi:10.3892/mmr.2017.7956
   PubMed Web of Science ®Google Scholar
• Nie W, Ni D, Ma X, et al. miR-122 promotes proliferation and invasion of clear cell renal cell carcinoma by suppressing Forkhead box O3 [published correction appears. Int J Oncol. 2019;54(2):559–571. doi:10.3892/ijo.2018.4636
   PubMed Web of Science ®Google Scholar
• Yang FQ, Yang FP, Li W, et al. Foxl1 inhibits tumor invasion and predicts outcome in human renal cancer. Int J Clin Exp Pathol. 2013;7(1):110–122.
   PubMed Web of Science ®Google Scholar
• Zhou L, Yin B, Liu Y, Hong Y, Zhang C, Fan J. Mechanism and function of decreased FOXO1 in renal cell carcinoma. J Surg Oncol. 2012;105(8):841–847. doi:10.1002/jso.23013
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhang L, Meng Y, Huang L. Benzyl isothiocyanate inhibits breast cancer cell tumorigenesis via repression of the FoxH1-mediated Wnt/β-catenin pathway. Int J Clin Exp Med. 2015;8(10):17601–17611.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Ye X, Chen R, et al. Sirtuin 7 promotes non-small cell lung cancer progression by facilitating G1/S phase and epithelial-mesenchymal transition and activating AKT and ERK1/2 signaling. Oncol Rep. 2020;44(3):959–972. doi:10.3892/or.2020.7672
   PubMed Web of Science ®Google Scholar
• Du B, Shim JS. Targeting epithelial-mesenchymal transition (EMT) to overcome drug resistance in cancer. Molecules. 2016;21(7):965. doi:10.3390/molecules21070965
   PubMed Web of Science ®Google Scholar
• Dong J, Zhai B, Sun W, Hu F, Cheng H, Xu J. Activation of phosphatidylinositol 3-kinase/AKT/snail signaling pathway contributes to epithelial-mesenchymal transition-induced multi-drug resistance to sorafenib in hepatocellular carcinoma cells. PLoS One. 2017;12(9):e0185088. doi:10.1371/journal.pone.0185088
   PubMed Web of Science ®Google Scholar
• Navas T, Pfister TD, Colantonio S, et al. Novel antibody reagents for characterization of drug- and tumor microenvironment-induced changes in epithelial-mesenchymal transition and cancer stem cells. PLoS One. 2018;13(6):e0199361. doi:10.1371/journal.pone.0199361
   PubMed Web of Science ®Google Scholar
• Wang H, Zhang B, Wang X, et al. TRPV4 overexpression promotes metastasis through epithelial-mesenchymal transition in gastric cancer and correlates with poor prognosis. Onco Targets Ther. 2020;13:8383–8394. doi:10.2147/OTT.S256918
   PubMed Web of Science ®Google Scholar
• Yin H, Wang X, Zhang X, et al. UBE2T promotes radiation resistance in non-small cell lung cancer via inducing epithelial-mesenchymal transition and the ubiquitination-mediated FOXO1 degradation. Cancer Lett. 2020;494:121–131. doi:10.1016/j.canlet.2020.06.005
   PubMed Web of Science ®Google Scholar
• Noda D, Itoh S, Watanabe Y, et al. ELAC2, a putative prostate cancer susceptibility gene product, potentiates TGF-beta/Smad-induced growth arrest of prostate cells. Oncogene. 2006;25(41):5591–5600. doi:10.1038/sj.onc.1209571
   PubMed Web of Science ®Google Scholar
• Yoshimatsu Y, Wakabayashi I, Kimuro S, et al. TNF-α enhances TGF-β-induced endothelial-to-mesenchymal transition via TGF-β signal augmentation. Cancer Sci. 2020;111(7):2385–2399. doi:10.1111/cas.14455
   PubMed Web of Science ®Google Scholar
• Nakao A, Imamura T, Souchelnytskyi S, et al. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J. 1997;16(17):5353–5362. doi:10.1093/emboj/16.17.5353
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang P, Shao M, et al. SALL4 activates TGF-β/SMAD signaling pathway to induce EMT and promote gastric cancer metastasis. Cancer Manag Res. 2018;10:4459–4470. doi:10.2147/CMAR.S177373
   PubMed Web of Science ®Google Scholar
• Gao Y, Zhao HY, Ren M, et al. TOP2A promotes tumorigenesis of high-grade serous ovarian cancer by regulating the TGF-β/Smad pathway. J Cancer. 2020;11(14):4181–4192. doi:10.7150/jca.42736
   PubMed Web of Science ®Google Scholar
• Zhang T, Liu W, Meng W, et al. down-regulation of miR-542-3p promotes cancer metastasis through activating TGF-β/Smad signaling in hepatocellular carcinoma. Onco Targets Ther. 2018;11:1929–1939. doi:10.2147/OTT.S154416
   PubMed Web of Science ®Google Scholar
• Dong HD, Diao HX, Zhao Y, et al. Overexpression of matrix metalloproteinase-9 in breast cancer cell lines remarkably increases the cell malignancy largely via activation of transforming growth factor-beta/SMAD signalling. Cell Prolif. 2019;52(5):e12633. doi:10.1111/cpr.12633
   PubMed Web of Science ®Google Scholar
• Tretbar S, Krausbeck P, Müller A, et al. TGF-β inducible epithelial-to-mesenchymal transition in renal cell carcinoma. Oncotarget. 2019;10(15):1507–1524. doi:10.18632/oncotarget.26682
   PubMedGoogle Scholar